Skip to main navigation Skip to search Skip to main content

Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles

  • Xing Ma
  • , Onn Shaun Ong
  • , Yanli Zhao*
  • *Corresponding author for this work
  • Nanyang Technological University

Research output: Contribution to journalArticlepeer-review

Abstract

Mesoporous silica nanoparticles (MSNPs) are functionalized with 15-mer single-stranded DNA (ssDNA). After loading of doxorubicin, functionalized MSNPs are capped with 33-mer complementary ssDNA through the formation of double-stranded DNA. Encapsulated doxorubicin could be released by either thermal-triggered denaturization of the DNA capping chains or redox-induced disulfide bond cleavage. An in vitro study shows successful delivery of doxorubicin into HeLa cells.

Original languageEnglish
Pages (from-to)912-917
Number of pages6
JournalBiomaterials Science
Volume1
Issue number9
DOIs
StatePublished - Sep 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles'. Together they form a unique fingerprint.

Cite this